March 11, 2024
Instead of using cellular reprogramming to directly treat age-related diseases, a perspective published in Nature Communications focuses on the opposite: using reprogrammed cells to form aged tissues and organoids on which to conduct experiments. Why not just use donors? Obviously, there is no shortage of age-related tissues in the world, and tissue donors can and...
May 15, 2023
In an open-access paper published in Cell Stem Cell this month, researchers have explained how organoids derived from human pluripotent stem cells (hPSCs) are being used to analyze diseases and develop treatments. Different sources for different conditions This review includes both human embryonic stem cells (hESCs), which are derived from the human organism at its...
February 16, 2023
Researchers publishing in Cell Stem Cell have used organoids derived from human cells to regrow the brain tissue of rats. The need to repair permanent damage BrainThe brain is perhaps the most important organ in the body. While many organs are critical to our survival, the brain contains the self. It is responsible for personality...
November 11, 2020
Using a novel 3D lung organoid model, new research published in Cell Stem Cell has shed light on the body's infection response to COVID-19. LungsOur lungs transfer ambient oxygen into the bloodstream while transferring out carbon dioxide. The airflow generated by our lungs also allows for speech as it passes through our vocal cords. Lung...
September 09, 2020
This is part one of a new weekly series focusing on recent advancements in the field of regenerative medicine. The field of tissue engineering and regenerative medicine Tissue engineering and regenerative medicine (TERM) is a large and rapidly growing field that has implications for the field of longevity. Broadly, the field of TERM is working...
March 03, 2020
Researchers from the Universities of Harvard and Tel Aviv have succeeded in linking up to 10 "organs-on-a-chip" via an analog of human vasculature. The invention allows for in vitro testing of drug toxicity and action, taking us one step closer to automated clinical trials and the development of personalized drugs. Chipping away at trial duration...